29 Reksa Dana Terbaik dengan RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock). Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.
Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel.
.
| Tanggal File |
Sumber |
Investor |
|
Ketik |
Presyo ng Avg
(Silangan) |
Saham |
Δ Saham
(%) |
Dilaporkan
Nilai
($1000) |
Nilai Δ
(%) |
Alokasi Port
(%) |
| 2025-07-29 |
NP |
GMEMX - GMO Emerging Markets Fund Class II
|
|
|
|
0 |
-100.00 |
0 |
-100.00 |
|
| 2025-08-27 |
NP |
RYWTX - Emerging Markets 2x Strategy Fund Class A
|
|
|
|
3,243 |
139.51 |
49 |
182.35 |
|
| 2025-06-26 |
NP |
HFIGX - Hartford Schroders Diversified Growth Fund Class I
|
|
|
|
4,778 |
15.27 |
67 |
15.79 |
|
| 2025-06-26 |
NP |
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class
|
|
|
|
1,360,890 |
0.00 |
18,944 |
0.72 |
|
| 2025-07-29 |
NP |
SGLIX - SGI Global Equity Fund Class I Shares
|
|
|
|
123,228 |
-10.41 |
1,814 |
3.19 |
|
| 2025-08-25 |
NP |
RECAX - RBC Emerging Markets ex-China Equity Fund Class A
|
|
|
|
102,000 |
0.00 |
1,533 |
13.98 |
|
| 2025-08-25 |
NP |
EMSQX - Shelton Emerging Markets Fund Institutional Shares
|
|
|
|
64,000 |
0.00 |
962 |
13.86 |
|
| 2025-03-28 |
NP |
GERIX - Goldman Sachs Emerging Markets Equity Insights Fund Institutional
|
|
|
|
271,917 |
232.55 |
3,758 |
-37.82 |
|
| 2025-08-29 |
NP |
JVANX - International Equity Index Trust NAV
|
|
|
|
18,540 |
0.00 |
279 |
13.93 |
|
| 2025-06-26 |
NP |
DAADX - Emerging Markets ex China Core Equity Portfolio Institutional Class
|
|
|
|
79,260 |
0.00 |
1,103 |
0.73 |
|
| 2025-08-28 |
NP |
JINTX - Johnson International Fund
|
|
|
|
18,400 |
0.00 |
277 |
14.05 |
|
| 2025-07-29 |
NP |
SIEYX - International Equity Portfolio Class A
|
|
|
|
4,130 |
-9.03 |
61 |
3.45 |
|
| 2025-06-23 |
NP |
UUPIX - Ultraemerging Markets Profund Investor Class
|
|
|
|
2,598 |
13.10 |
36 |
16.13 |
|
| 2025-06-26 |
NP |
FSGJX - Fidelity SAI Global ex U.S. Low Volatility Index Fund
|
|
|
|
985,057 |
-12.72 |
13,712 |
-12.09 |
|
| 2025-08-28 |
NP |
SIEMX - SIT EMERGING MARKETS EQUITY FUND - CLASS F, effective 1-31-2017 (formerly Class A)
|
|
|
|
523,732 |
-13.51 |
7,872 |
-1.45 |
|
| 2025-06-30 |
NP |
VMNVX - Vanguard Global Minimum Volatility Fund Admiral Shares
|
|
|
|
1,609,594 |
8.26 |
22,406 |
9.04 |
|
| 2025-06-30 |
NP |
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares
|
|
|
|
1,970,589 |
0.00 |
27,431 |
0.72 |
|
| 2025-04-28 |
NP |
GMAQX - GMO Emerging Markets ex-China Fund Class VI
|
|
|
|
11,200 |
133.33 |
143 |
-61.14 |
|
| 2025-08-27 |
NP |
HCEMX - The Emerging Markets Portfolio HC Strategic Shares
|
|
|
|
55,157 |
-8.03 |
829 |
4.80 |
|
| 2025-08-21 |
NP |
MEMSX - Mercer Emerging Markets Equity Fund Class I
|
|
|
|
127,064 |
-5.14 |
1,910 |
8.10 |
|
| 2025-07-28 |
NP |
AVEEX - Avantis Emerging Markets Equity Fund Institutional Class
|
|
|
|
30,679 |
0.00 |
452 |
15.05 |
|
| 2025-06-26 |
NP |
EMQAX - Ashmore Emerging Markets Active Equity Fund CLASS A
|
|
|
|
24,504 |
|
341 |
|
|
| 2025-07-29 |
NP |
GBFFX - GMO Benchmark-Free Fund Class III
|
|
|
|
39,560 |
0.00 |
582 |
15.25 |
|
| 2025-06-24 |
NP |
GAOAX - JPMorgan Global Allocation Fund Class A
|
|
|
|
24,489 |
|
341 |
|
|
| 2025-06-30 |
NP |
VGTSX - Vanguard Total International Stock Index Fund Investor Shares
|
|
|
|
874,071 |
-5.55 |
12,167 |
-4.86 |
|
| 2025-03-27 |
NP |
EMXIX - Ashmore Emerging Markets Equity ex China Fund Institutional Class
|
|
|
|
10,575 |
400.00 |
146 |
-6.41 |
|
| 2025-07-29 |
NP |
GIMFX - GMO Implementation Fund
|
|
|
|
82,955 |
0.00 |
1,221 |
15.19 |
|
| 2025-05-27 |
NP |
SBHEX - Segall Bryant & Hamill Emerging Markets Fund Retail Class
|
|
|
|
19,900 |
0.00 |
262 |
-16.56 |
|
| 2025-08-27 |
NP |
RMEAX - Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares
|
|
|
|
18,163 |
-51.27 |
273 |
-44.60 |
|
